Craig Hartley, Ph.D.

Dr. Hartley is currently Vice President of Finance for the Engineering in Medicine and Biology Society of the IEEE. Since 1993 he has served on an NIH study section which reviews SBIR proposals related to cardiovascular devices. Dr. Hartley has contributed to the product lines of several small businesses including Indus Instruments, Crystal Biotech, Triton Technologies, and Primetech Corp. His laboratory at Baylor-Methodist continues to manufacture and supply ultrasonic instrumentation and transducers to laboratories in the US, Europe, and Asia.

Harvey Hecht, M.D.

Dr. Hecht is an expert in cardiac imaging and preventive cardiology, and is the author of more than 100 publications in peer reviewed journals. He completed his internship and residency in Internal Medicine at the Albert Einstein College of Medicine and Mount Sinai Hospital (NY) and a fellowship in Cardiology at Beth Israel Hospital, Harvard Medical School. His academic appointments have included Instructor in Medicine at Harvard Medical School, Assistant Professor at UCLA, Associate Professor at the University of Southern California and University of California, San Francisco, and Clinical Professor of Medicine at the Albert Einstein College of Medicine . A graduate of Columbia College and the Albert Einstein College of Medicine, Dr. Hecht is board certified in Internal Medicine and Cardiovascular Diseases, and is a Fellow of the American College of Cardiology. He is a consultant to the editors of numerous cardiovascular publications, including the Journal of the American College of Cardiology, American Journal of Cardiology, Circulation, American Heart Journal, Journal of Invasive Cardiology, and the Journal of the American Society of Echocardiography. He is one of the founders of, and was the first President of the Society of Atherosclerosis Imaging, as well as one of the founders of the Society of Cardiovascular Computed Tomography. He has been involved in early stage development of several startup companies in the medical arena which have had successful IPO’s.

Ioannis Kakadiaris, Ph.D.

Dr. Kakadiaris in an Associate Professor in the Departments of Computer Science and Electrical and Computer Engineering at the Universtiy of Houston.  He is also the Director of the Division of Bio-Imaging and Bio-Computation at the University of Houston Institute for Digital Informatics and Analysis.  Dr. Kakadiaris earned his doctorate degree at the University of Pennsylvania.

Stanley Kleis, Ph.D.

Dr. Kleis is an Associate Professor of Mechanical Engineering at the University of Houston. Dr. Kleis, who holds a Ph.D. from Michigan State University, has worked with NASA for nearly 20 years to enhance the functionality of its bioreactors. He was principle investigator on two space shuttle flight experiments and received one of NASA’s highest honors, the Public Service Medal.  He has expertise in fluid mechanics and heat and mass transport with emphasis on experimental measurements and applied computational fluid dynamics. Dr. Kleis is a member of Endothelix Scientific Advisory Board.

Gary McQuilkin, M.S.

Mr. McQuilkin obtained his M.S. degree from Purdue University in electrical engineering with an emphasis on biomedical applications. His 30 years of experience include Doppler ultrasound, ultrasonic catheters, acoustic field mapping, arterial pressure measurement, medical telemetry, physiological sensors, mathematical modeling of the cardiovascular system, digital and analog signal processing, and thermal image processing. As a Medtronic engineer, he helped establish a technical basis for early telemetry systems used with implantable devices. He founded Medwave to develop continuous, noninvasive blood pressure technology, progressing from concept, through development, attracting five successful rounds of venture capital investment serving as President, Chairman, and Vice President of Research and Development. He holds patents in the areas of pacemaker telemetry, detection of fibrillation thresholds, blood pressure measurements, thermal imaging and volumetric scanning. He serves Endothelix as Interim VP of Research and Development.

Ralph Metcalfe, Ph.D.

Dr. Metcalfe is a Professor of Mechanical and Biomedical Engineering and Mathematics at the University of Houston. His research focuses on numerical simulations of blood flow in normal and diseased arteries. Before joining the University of Houston, Dr. Metcalfe was a Senior Research Scientist at Flow Industries (NASDAQ: FLOW) as a startup company. He received his Ph.D. in Applied Mathematics from the Massachusetts Institute of Technology.